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Background:  The  recent  emergence  of Chikungunya  Virus  (CHIKV)  in  the  Americas  constitutes  a major
public  health  problem  on this  continent,  where  the  mosquito  vector  is  widespread.  The  rapid  diagnosis
of  suspected  cases  is essential  for the  monitoring  and  control  of this  ongoing  outbreak.  However,  this
requires  reliable  tools  that  are  difﬁcult  to establish  in areas  without  specialized  laboratories.
Objectives:  The  aim  was to evaluate  the performances  of  serum  samples  spotted  onto  ﬁlter  paper  for
molecular  and serological  diagnosis  of  Chikungunya  infection.
Study  design:  Analyses  were  performed  from  frozen  sera  and  serum  spotted  onto  ﬁlter  paper  provided
from  121  Chikungunya  suspected  cases  collected  at  a  biological  laboratory  on  Saint-Martin  Island.
Results:  This  approach  performed  well  in  comparisons  with  standard  methods,  with a sensitivity  of  100%
and  a  speciﬁcity  of  93.6%  for the  combined  technical  approaches  (RT-PCR  and  serological  results).  Com-
parisons  of serum  samples  spotted  onto  ﬁlter  paper  and  frozen  samples  showed  a concordance  rate  of
94.8%  in  molecular  tests  and  98.2%  in  serological  tests.
Conclusions:  This  simple  sampling  technique  could overcome  the  problems  of the  lack  of  efﬁcient  CHIKV
diagnosis  tools  in  remote  regions,  providing  good  results  regardless  of the  molecular  or  serological
approach  used.  This simple  ﬁlter  paper-based  method  can  be used  to  diagnose  both  chikungunya  and
dengue  infections,  as  previously  demonstrated  following  transport  at ambient  temperature  to special-
ized  laboratories.  Given  the  set-up  costs  and  high  performance  of  this  method,  it could  be recommended
for  the  monitoring  and  control  of  Chikungunya  virus  expansion  in  the  Americas  and  in  other  affected
regions.
©  2015  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the CC. Background
Chikungunya is a mosquito-borne disease caused by an
lphavirus from the Togaviridae family. The virus is transmitted
y the bite of Aedes mosquitoes, including Aedes aegypti and Aedes
lbopictus [1]. The disease is typically an acute illness characterized
y sudden-onset fever, rash, and incapacitating arthralgia, which
ay  persist for weeks, months or years after the acute phase of
nfection [2]. No licensed vaccine or speciﬁc treatment for Chikun-
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y-nc-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
gunya infection is currently available. The only effective mean of
prevention is to protect individuals against mosquito bites.
Chikungunya has spread across Africa, South Asia, and the Indian
Subcontinent. In 2005, Chikungunya Virus (CHIKV) emerged in the
Indian Ocean region and caused major epidemics, on Reunion Island
in particular, where it affected about 300,000 inhabitants [3]. In
December 2013, the circulation of CHIKV was reported for the ﬁrst
time in French part of Saint-Martin Island in the Caribbean region
[4,5]. Investigations of the ﬁrst conﬁrmed cases revealed that the
virus concerned was of the Asian genotype [6]. The emergence of
CHIKV on Saint-Martin was  rapidly followed by outbreaks on other
neighboring islands, such as Saint-Barthelemy, Martinique, Guade-
loupe, and the British Virgin Islands, and a large outbreak is now
considered to be underway in the Americas [7,8]. As of June 2015,
the World Health Organization reported that there had been more
than 1 million suspected cases and around 30,000 conﬁrmed CHIKV
ss article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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ases in the Americas [8]. This rapid expansion constitutes a major
roblem for public health services in the Americas, because the
osquito vector is present in a wide geographic zone extending
rom North America to Brazil [9]. In the absence of an effective vac-
ine or speciﬁc treatment, the rapid diagnosis of suspected CHIKV
ases is important, for monitoring and controlling this expansion,
articularly in regions not yet affected, and to distinguish between
HIKV and dengue virus infections, dengue virus being another
ndemic arbovirus transmitted by the same vector in the Ameri-
as. The following strategy is used for CHIKV diagnosis: for serum
ollected during the ﬁrst seven days after the onset of symp-
oms, real-time reverse transcription-polymerase chain reaction
RT-PCR) is used to detect the viral genome; for serum collected
n or after day 5, serologic techniques are used to detect IgM and
gG responses to the virus [10]. Molecular diagnosis is sensitive and
peciﬁc, but requires specialized technical support and equipment
hat are difﬁcult to obtain in remote areas. Moreover, commercially
vailable serologic diagnostic tests for CHIKV have been shown
o have a low sensitivity and speciﬁcity [11]. All these difﬁculties
amper the diagnosis, monitoring and control of CHIKV infections
n the Americas and other tropical regions in which this virus is
irculating.
We have already shown that dried blood spotted onto ﬁlter
aper is a useful alternative to frozen samples for the diagnosis of
engue infection in patients living in low-income countries [12,13].
ther studies have also demonstrated that this approach is suitable
or the molecular and serological diagnosis of bacterial and parasitic
iseases [14,15].
. Objectives
To facilitate testing and to limit the costs of transporting samples
or CHIKV testing, in the cold, to specialized laboratories, we eval-
ated the use of serum spotted onto ﬁlter paper for the molecular
nd serological diagnosis of CHIKV.
. Study design
.1. Specimen collection
Due to the lack of local specialized laboratories able to diagnose
HIKV infection in Saint-Martin, a biological laboratory located
n the French part of the island organized, in collaboration with
he Regional Health Agency, the transport of all samples from
atients with suspected CHIKV to the French National Reference
enter (FNRC) for Arboviruses in Marseille, France (Marseille-Lab)
or biological investigations [16]. Molecular and serological diagno-
is techniques were used; depending on the time elapsed between
he onset of symptoms and sample collection for each patient
10]. In parallel to the shipment of frozen serum to Marseille-Lab,
erum samples spotted onto ﬁlter paper (Whatman 3 M; Scheilcher
 Schuell, Germany) were also obtained for 121 patients with
uspected CHIKV infection. Brieﬂy, venous blood samples were col-
ected from these 121 patients. They were rapidly centrifuged and
he resulting serum sample was divided in two. One portion of the
ample was stored at −20 ◦C until shipment to Marseille-Lab and
he other was spotted onto ﬁlter paper (three spots of 20 L). These
erum samples spotted onto ﬁlter paper were placed in individual,
abeled and hermetic plastic bag, respecting the shipping guide-
ines for dried blood spots [17]. These samples were sent by post at
mbient temperature (20–25 ◦C and 85–90% relative humidity) to
he French National Reference Center for Arboviruses in Cayenne
Cayenne-Lab). After, an average delay of reception of 10 days, these
amples were stored at −80 ◦C during 8 days before the begin-
ing of molecular and serological analyses. For each patient: one ofl Virology 71 (2015) 89–92
the spots was used for molecular diagnosis, another for “in house”
serological analysis, and the ﬁnal spot was  retained as a poten-
tial control. In accordance with the information provided by the
patients (date of onset of disease and date of sample collection),
the two  laboratories analyzed 61 samples by real-time RT-PCR, 25
by immune-capture method and 35 by both techniques.
3.2. Molecular and serological analyses performed by
Marseille-Lab
For molecular diagnosis, RNA was extracted from 140 L of
serum with the QIAamp® Viral RNA kit, as recommended by the
manufacturer’s protocol (Qiagen, Hilden Germany), and the CHIKV
genome was detected by real-time RT-PCR targeting the E1 gene,
as previously described [18]. For IgM detection, we used an “in-
house” IgM antibody-capture enzyme-linked immunoabsorbent
assay (MAC-ELISA), with precipitated and inactivated virus pro-
duced in cell culture as the antigen, as previously described [19].
3.3. Molecular and serological analyses performed by
Cayenne-Lab
For each patient tested, two  spots of serum spotted onto ﬁlter
paper (SFP) were cut out and placed in two  independent 1.8 mL
sterile tubes for molecular and serological analyses.
For the molecular investigation, viral RNA was extracted from
the serum spot on ﬁlter paper for each patient and from 10 L of
serum from a CHIKV-positive control. RNA was extracted with the
QIAamp® Viral RNA kit (Qiagen, Hilden Germany). Each sterile tube
containing a cut serum spot from a patient (20 L) and those con-
taining control samples were incubated in 560 L of AVL buffer for
15 min  for lysis. We  added 560 L of ethanol (96–100%) and mixed
by pulse-vortexing for 15 s. We then loaded 630 L of the solu-
tion obtained on a QIAamp Mini column, which we centrifuged at
6000 × g for 1 min. The following steps of the extraction procedure
were then carried out as described by the manufacturer (Qiagen,
Hilden Germany). Finally, all 96 extracted RNA samples were ana-
lyzed by real-time RT-PCR targeting the NSP1 gene of CHIKV, as
described by Panning et al. [20].
Similarly, 60 SFP samples were analyzed for CHIK IgM antibod-
ies by antibody capture MAC-ELISA, with an “in-house” protocol.
Sterile tubes containing one cut spot (20 L) were incubated for
2 h in 600 L of phosphate-buffered saline (PBS) 1X supplemented
with 0.5% Tween 20 and 5% non-fat dried milk (PBS-T NDM). Each
eluate obtained was used in the MAC-ELISA test, as described by
Talarmin et al. [21]. In this serological method, the CHIKV antigens
used were derived from a suckling mouse brain preparation.
3.4. Statistical analysis
The results of the molecular and serological assays performed
with SFP were compared to those obtained with frozen serum,
which was considered to be the gold standard. The sensitivity and
speciﬁcity of the assays were determined with two-by-two tables,
as widely used in the evaluation of diagnostic methods.
4. Results
During December 2013, 121 samples from patients with sus-
pected CHIK from Saint-Martin Island were used to evaluate the
performance of Chikungunya infection diagnosis from serum spot-
ted onto ﬁlter paper, by molecular and/or serological techniques.
The patients had presented at the biological laboratory of Saint-
Martin with fever, headache, myalgia and severe joint pain. The
Marseille-Lab used thawed frozen serum samples and Cayenne-Lab
S. Matheus et al. / Journal of Clinical Virology 71 (2015) 89–92 91
Table  1
Overall sensitivity and speciﬁcity of tests performed on SFP specimens for the diag-
nosis of CHIKV infection.
Results with
serum on ﬁlter
paper
Results of standard methods with serum samplesa
Positive Negative Total
Positive 55 4 59
Negative 0 59 59
Equivocal 1 2 3
Total 56 65 121
a RT-PCR or serology.
Table 2
Sensitivity and speciﬁcity of real-time RT-PCR diagnostic tests for CHIKV.
Results with
serum on ﬁlter
paper
Results of standard methods with serum samples
Positive Negative Total
Positive 38 2 40
Negative 3 53 56
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Table 3
Sensitivity and speciﬁcity of serological tests for the diagnosis of CHIKV infection.
IgM detection
with serum on
ﬁlter paper
Results of standard methods with serum samples
Positive Negative Total
Positive 15 1 16
Negative 0 42 42
reported similar results, with a concordance rate of 93.9% and aTotal 41 55 96
sed dried serum spots on ﬁlter paper from the same correspond-
ng patient and collection time, for all PCR and serology testing
erformed. Each laboratory used its own techniques for molecular
nd serological diagnosis. The participation of the two laboratories
t a European quality control of CHIKV has previously shown the
xcellent concordant results between the two laboratories (data
ot shown). According to the time interval between disease onset
nd sample collection, 96 samples collected in the ﬁrst seven days
f the disease were tested by real-time RT-PCR, and 60 samples
ollected from day 5 onwards were tested by MAC-ELISA.
The Marseille-Lab reported that 56 of the 121 samples tested
ositive for CHIKV by at least one technique (real-time RT-PCR
nd/or serology), whereas 65 samples tested negative by both tech-
iques. At the Cayenne-Lab, 59 samples tested positive and 59
ested negative. The other three samples were considered equiv-
cal; 2.5% of the results were therefore inconclusive (Table 1).
he concordance rate between the two laboratories was 96.6%
114/118). The overall sensitivity and speciﬁcity of this approach
ere 100% (55/55) and 93.6% (59/63; conﬁdence interval [CI]:
.87–0.99), respectively, with respect to the gold standard method.
.1. Comparison of the molecular results obtained with frozen
erum samples and SFP
In total, 96 patients were tested for Chikungunya infection by
eal-time RT-PCR: 38 tested positive and 53 tested negative, regard-
ess of the nature of the biological material tested (Table 2). Frozen
erum and SFP gave identical results for 91 patients (94.8%–91/96)
nd discordant results for the other ﬁve samples (5.2%–5/96). Three
f the patients with discordant results tested positive with frozen
erum samples and negative with the corresponding SFP. However,
erological tests gave positive results for two of these three patients.
he other two  patients with discordant results tested negative with
rozen serum and positive with ﬁlter paper. These samples were
ollected on days 0 and 1 of the disease and were therefore not
nvestigated by serological techniques. The kappa coefﬁcient was
.89 (95% CI: 0.80–0.98). The sensitivity and speciﬁcity of molec-
lar Chikungunya diagnosis from SFP were 92.6% (38/41, 95% CI:
.84–1.00) and 96.3% (53/55, 95% CI: 0.91–1.00), respectively.Equivocal 1 1 2
Total 16 44 60
4.2. Comparison of the serological results obtained with frozen
serum samples and SFP
As for molecular analyses, each FNCR used its speciﬁc “in-house”
serological protocol. Equivocal results were obtained for only two  of
the 60 patients investigated by MAC-ELISA, corresponding to 3.3%
inconclusive results (2/60) (Table 3). Inconclusive results aside, the
results obtained with SFP and frozen serum samples were con-
cordant for 57 of 58 (98.2%) samples and discordant for only one
sample collected on day 5 after the onset of symptoms. This sam-
ple, which tested positive for IgM at the Cayenne-Lab and negative
at the Marseille-Lab, gave a positive result in real-time RT-PCR per-
formed at the Marseille-Lab. The kappa coefﬁcient was 0.97 (95%
CI: 0.93–1.00). The sensitivity and speciﬁcity of Chikungunya MAC-
ELISA performed on SFP were 100% (15/15) and 97.6% (42/43; 95%
CI: 0.93–1.00), respectively. Due to recent cases of Dengue in Saint-
Martin, the two  FNRCA laboratories also tested for the possible
presence of dengue IgM antibodies in the 60 patients from whom
samples were collected after day 5 of the disease. These investiga-
tions led to the detection of dengue IgM in 15 samples for which
CHIKV infection had been ruled out (data not shown). These results
were concordant for the two  FNCR laboratories, regardless of the
type of biological support and technique used.
5. Discussion
Since the emergence of CHIKV in the Americas, a number of
outbreaks have been reported in some of the countries of this con-
tinent. Efﬁcient diagnostic tools suitable for the monitoring and
control of this arboviral disease in remote areas are lacking. The
aim of this study was, therefore, to evaluate the performance of
SFP for the diagnosis of CHIKV infection.
The overall sensitivity and speciﬁcity, for the combined techni-
cal approaches used on SFP, were 100% and 93.6%, respectively. The
concordance rates between the two  FNCR laboratories regardless of
the biological material (SFP vs. frozen serum samples) and techni-
cal protocol used were 94.8% for molecular diagnosis and 98.2% for
serological diagnosis. The Kappa coefﬁcients were 0.89 and 0.97,
respectively. The good concordance obtained by the two labora-
tories in the framework of a CHIKV Quality-Control organized by
an European organization can ruled out the variability linked at
the different technical protocols used by the two laboratories. The
lowest concordance observed in particular for molecular diagnosis
in comparison to serological diagnosis could be explained by the
fact that the volume of specimen used for RNA extraction was dif-
ferent. The condition of transportation over ambient temperature
could also have an impact on the concordance, due to the fragility
of nucleic acids compared to antibodies.
Andriamandiny et al., who evaluated the usefulness of capillary
samples applied to ﬁlter paper for the molecular detection of CHIKVkappa coefﬁcient of 0.87 [22]. Overall, these ﬁndings indicate that
the collection of samples on ﬁlter paper is suitable for the molecular
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[26] International Society for Infectious Diseases. PRO/EDR - Zika virus - Brazil:2 S. Matheus et al. / Journal of
iagnosis of CHIKV, regardless of the nature of the sample collected:
erum or capillary blood samples.
Serological investigations for the 60 patients with suspected
HIKV infection also performed well, with a sensitivity of 100%
nd a speciﬁcity of 97.6%. However, as sensitivity was estimated
ith only a small number of samples, these results must be
nterpreted with caution. These performances and the concordant
esults obtained in this evaluation suggest that serological investi-
ations are more efﬁcient than molecular investigations using this
pproach. As advanced above, the better stability of the antibodies
potted in to ﬁlter paper compared to nucleic acids could explain
his difference.
Overall, these results demonstrate that ﬁlter paper is a con-
enient format for the virological and serological diagnosis of
HIKV infection, particularly in regions lacking specialized labora-
ories capable of performing the biological investigations required.
ndeed, this approach makes it possible to overcome the require-
ent for cold storage during transport, as already shown for other
rboviruses [23–25]. This approach is thus cheaper than the ship-
ent of frozen samples. In the epidemiological context of the
mericas, where the Dengue and Chikungunya viruses are cur-
ently cocirculating, the simple collection of samples from patients
ith suspected arbovirus infections on ﬁlter paper could make
t possible to identify the virus involved in the infection, and to
nhance diagnosis and surveillance processes. The recent reports
f Zika cases in Brazil also provide an opportunity to extend this
pproach to the diagnosis of a wider range of arboviruses [26,27].
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